When stratified by inflammatory profiles, patients with asthma-associated biomarkers (elevated IgE or eosinophils) exhibited significantly higher frequencies of wheezing (p < 0.001) and bronchovascular prominence (p = 0.035) compared to those with normal biomarker levels, despite similar symptom durations (Table 4). This evidence concerns the gene IGHE and asthma.